Merck & Co and UnitedHealth Group are set to exit the urologic cancer diagnostics technology provider in an acquisition by Veracyte.

The Cambrian Biopharma-backed cancer treatment developer floated above its range in an offering on the Nasdaq Global Market.

The Tencent and Baidu-backed livestreaming app saw its shares almost triple on the first day of trading and is now valued at about $160bn.

The corporate-backed genetic testing service is joining forces with an NYSE-listed special purpose acquisition company sponsored by Virgin Group.

The Alphabet-backed immunotherapy developer secured nearly $588m in what was reputedly the largest ever flotation for a preclinical life sciences company.

The Ping An and SIG-backed cross-border payment services provider will list on the Nasdaq Capital Market through the merger with FTAC Olympus Acquisition Corp.

Harvard-linked Sana brought in nearly four times as much in proceeds as originally planned and saw shares surge 40% on the first day of trading.

Virginia Tech spinout Landos Biopharma priced its shares at $16 to raise $100m and will use proceeds to advance the development of two treatments for inflammatory bowel disease.

Airbus Ventures-backed space launch services provider Astra will get a listing on the Nasdaq Capital Market through the deal.

HY Energy and Yake Food-backed starch sugar additive manufacturer Zhejiang Huakang Pharmaceutical is set to go public in Shanghai.